‎Julphar to inject SAR 300M in pharma, biotech facility in Saudi Arabia

Gulf Pharmaceutical Industries (Julphar) unveiled plans to invest nearly SAR 300 million (AED 293 million) over the few coming years to build a state-of-art pharma and biotech manufacturing facility in Saudi Arabia.

Advertisement

The green field project will include complex biologics, sterile and general formulation drug manufacturing and will follow the highest quality standards, fulfilling SFDA, EMA, and USFDA guidelines.

Gulf Pharmaceutical Industries (Julphar) unveiled plans to invest nearly SAR 300 million (AED 293 million) over the few coming years to build a state-of-art pharma and biotech manufacturing facility in Saudi Arabia.

The green field project will include complex biologics, sterile and general formulation drug manufacturing and will follow the highest quality standards, fulfilling SFDA, EMA, and USFDA guidelines.